Lenvatinib

ATC L01EX08 · 9 markets · 80 records

Lenvatinib 9 markets · 80 records Forms

CN 40 records · 2 strengths

  • 4 mgcapsule乐卫玛甲磺酸仑伐替尼__mah__:乐普药业科技有限公司、__mah__:先声药业有限公司、__mah__:南京正大天晴制药有限公司、__mah__:吉林敖东洮南药业股份有限公司、__mah__:山东新时代药业有限公司、__mah__:成都倍特药业股份有限公司、__mah__:扬子江药业集团有限公司、__mah__:正大天晴药业集团股份有限公司 +7 also in CA·GB·US +2
  • 10 mgcapsule乐卫玛甲磺酸仑伐替尼__mah__:乐普药业科技有限公司、__mah__:吉林敖东洮南药业股份有限公司、__mah__:成都倍特药业股份有限公司、__mah__:正大天晴药业集团股份有限公司、__mah__:湖南科伦制药有限公司 also in CA·GB·US +2

CA 8 records · 8 strengths

GB 6 records · 2 strengths

US 5 records · 2 strengths

AU 2 records · 2 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 Lenvima

    EU 2 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Kisplyx 4mg capsules、Lenvima

      MX 1 records · 1 strengths

        Records without a stated strength · 1 SYNTIR

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.